Sirtuin Pathway

Overview

Sirtuins are a family of evolutionarily conserved enzymes that couple the removal of acetyl groups from protein lysine residues to the hydrolysis of nicotinamide adenine dinucleotide (NAD+). Because their enzymatic activity requires NAD+ as a co-substrate, sirtuins function as metabolic sensors: when NAD+ levels are high (indicating active metabolism, caloric restriction, or exercise), sirtuin activity increases. When NAD+ levels fall (with aging, overnutrition, or metabolic dysfunction), sirtuin activity declines.

The founding member, Sir2 (silent information regulator 2), was discovered in yeast as a gene required for transcriptional silencing and lifespan extension during caloric restriction. Mammals possess seven sirtuins (SIRT1-7) with distinct subcellular localizations, substrate specificities, and biological functions. Collectively, the sirtuins regulate epigenetic gene expression, DNA repair, mitochondrial metabolism, inflammation, circadian rhythm, and cellular stress resistance — placing them at the center of aging biology and longevity research.

How It Works

Enzymatic Mechanism

All sirtuins share a conserved catalytic domain of approximately 275 amino acids that catalyzes the NAD+-dependent deacetylation reaction:

1. The acetylated protein substrate and NAD+ bind to the sirtuin active site
2. The enzyme cleaves NAD+ into nicotinamide and ADP-ribose
3. The acetyl group is transferred from the lysine residue to ADP-ribose, producing O-acetyl-ADP-ribose (OAADPr)
4. The deacetylated protein and OAADPr are released

This reaction has two important consequences. First, nicotinamide is released as a product and acts as a sirtuin feedback inhibitor — the enzyme NAMPT (nicotinamide phosphoribosyltransferase) recycles nicotinamide back to NMN and then NAD+ via the salvage pathway, making NAMPT a rate-limiting regulator of sirtuin activity. Second, one molecule of NAD+ is consumed per deacetylation event, directly coupling sirtuin activity to cellular metabolic state.

Some sirtuins (particularly SIRT4 and SIRT6) also possess mono-ADP-ribosyltransferase activity, and SIRT5 has desuccinylase and demalonylase activities in addition to deacetylase function.

Individual Sirtuin Functions

SIRT1 (Nucleus/Cytoplasm)

• The most extensively studied mammalian sirtuin
• Deacetylates histones (H3K9ac, H4K16ac, H1K26ac), promoting epigenetic silencing
• Deacetylates and activates PGC-1alpha, promoting mitochondrial biogenesis and fatty acid oxidation
• Deacetylates and activates FOXO1/3/4 transcription factors, promoting stress resistance genes (SOD2, catalase)
• Deacetylates and inhibits p53, suppressing apoptosis under metabolic stress
• Deacetylates and inhibits NF-kB (RelA/p65), reducing inflammatory signaling
• Deacetylates LXR and SREBP, modulating lipid metabolism
• Forms a positive feedback loop with AMPK: AMPK increases NAD+ levels (via fatty acid oxidation), activating SIRT1; SIRT1 deacetylates and activates LKB1, which activates AMPK

SIRT2 (Cytoplasm/Nucleus)

• Primary cytoplasmic sirtuin; deacetylates alpha-tubulin, regulating microtubule dynamics
• Deacetylates FOXO3a in the cytoplasm during oxidative stress
• Regulates cell cycle progression through deacetylation of histone H4K16 during mitosis
• Modulates adipocyte differentiation by deacetylating FOXO1

SIRT3 (Mitochondrial matrix)

• The primary mitochondrial deacetylase; over 65% of mitochondrial proteins are acetylated
• Deacetylates and activates SOD2 (manganese superoxide dismutase), the primary mitochondrial antioxidant
• Deacetylates enzymes of the electron transport chain (complex I, II, III), TCA cycle (IDH2), and fatty acid oxidation (LCAD)
• Essential for mitochondrial metabolic adaptation during fasting and caloric restriction
• SIRT3 knockout mice develop metabolic syndrome and accelerated aging phenotypes

SIRT4 (Mitochondrial matrix)

• Primarily an ADP-ribosyltransferase rather than a deacetylase
• ADP-ribosylates and inhibits glutamate dehydrogenase (GDH), regulating amino acid-stimulated insulin secretion
• Represses fatty acid oxidation under nutrient-replete conditions
• Acts as a tumor suppressor by maintaining genomic stability

SIRT5 (Mitochondrial matrix)

• Weak deacetylase; strong desuccinylase, demalonylase, and deglutarylase
• Regulates the urea cycle (deacetylates CPS1, carbamoyl phosphate synthetase 1)
• Desuccinylates and activates SOD1
• Regulates fatty acid oxidation and ketogenesis

SIRT6 (Nucleus — chromatin-associated)

• Deacetylates H3K9ac and H3K56ac at telomeres and DNA damage sites
• Essential for base excision repair (BER) and double-strand break repair
• ADP-ribosylates PARP1, promoting DNA repair
• Suppresses NF-kB-driven inflammatory gene expression
• SIRT6 knockout mice display accelerated aging; SIRT6 overexpression extends male mouse lifespan

SIRT7 (Nucleolus)

• Deacetylates H3K18ac, a mark associated with active transcription
• Regulates ribosomal DNA (rDNA) transcription by RNA polymerase I
• Involved in the DNA damage response and ribosome biogenesis
• Required for maintaining the transformed state of cancer cells

NAD+ as the Master Regulator

The dependence of all sirtuins on NAD+ makes NAD+ metabolism a central determinant of sirtuin function:

• NAD+ biosynthesis — The de novo pathway (from tryptophan), Preiss-Handler pathway (from nicotinic acid), and salvage pathway (from nicotinamide via NAMPT) all generate NAD+
• NAD+ decline with age — NAD+ levels decrease with aging in multiple tissues, attributed to increased NAD+ consumption by CD38 (a NAD+ glycohydrolase that increases with age-related inflammation) and decreased NAMPT expression
• NAD+ precursors — Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) bypass the rate-limiting NAMPT step and are investigated as NAD+-boosting supplements

Key Components

Role in Peptide Research

MOTS-c and the AMPK-Sirtuin Axis

The mitochondrial-derived peptide MOTS-c activates AMPK, which increases NAD+ levels through enhanced fatty acid oxidation, thereby activating SIRT1. This MOTS-c → AMPK → NAD+ → SIRT1 axis may contribute to the metabolic and potential longevity benefits attributed to MOTS-c in preclinical research.

Humanin

Humanin, a 24-amino acid mitochondrial-derived peptide, intersects with sirtuin biology through its effects on mitochondrial function and metabolic homeostasis. Humanin has been shown to improve mitochondrial respiration and reduce oxidative stress — effects consistent with SIRT3-mediated mitochondrial quality control.

Epitalon and Telomere Biology

Epithalon (epithalon), a tetrapeptide analog of epithalamin, is investigated for its effects on telomerase activation. SIRT6 is a critical regulator of telomere integrity, deacetylating H3K9 and H3K56 at telomeric chromatin. The intersection of epitalon's reported telomere effects with SIRT6-dependent telomere maintenance is an area of emerging interest in longevity peptide research.

GH Secretagogues and Sirtuin Balance

The growth hormone axis and sirtuins operate in a complex regulatory relationship. SIRT1 modulates GH receptor signaling and IGF-1 sensitivity. The anabolic drive from GH secretagogues activates mTOR, which tends to suppress SIRT1 and AMPK activity, creating a tension between growth-promoting and longevity-promoting pathways that is relevant to peptide protocol design.

Clinical Significance

• Aging — Sirtuin activity declines with age due to falling NAD+ levels. Genetic overexpression of SIRT1 or SIRT6 extends lifespan in mice. Caloric restriction, the most robust lifespan-extending intervention, activates sirtuins through increased NAD+ availability.
• Metabolic disease — SIRT1 and SIRT3 are protective against type 2 diabetes, non-alcoholic fatty liver disease, and obesity. SIRT1 activators (resveratrol, SRT2104) have been investigated clinically for metabolic benefits.
• Neurodegeneration — SIRT1 activation is neuroprotective in models of Alzheimer's and Parkinson's disease through p53 deacetylation, FOXO activation, and NF-kB inhibition. NAD+ repletion strategies are in clinical trials for neurodegenerative conditions.
• Cancer — Sirtuins have dual roles: SIRT1 can suppress tumors (via p53 deacetylation-independent mechanisms and DNA repair) or promote them (via p53 inactivation). SIRT6 is generally tumor-suppressive; its loss accelerates tumorigenesis.
• Cardiovascular disease — SIRT1 and SIRT3 protect against atherosclerosis, cardiac hypertrophy, and heart failure through anti-inflammatory, antioxidant, and metabolic mechanisms.
• Inflammatory disease — SIRT1-mediated NF-kB deacetylation suppresses chronic inflammatory signaling, relevant to autoimmune disease, chronic obstructive pulmonary disease, and inflammaging.

Related Topics

• AMPK Pathway — AMPK and SIRT1 form a bidirectional activation loop
• mTOR Pathway — Antagonistic relationship; mTOR suppresses sirtuin activity
• Epigenetic Regulation — Sirtuins are histone deacetylases regulating chromatin state
• Mitochondrial Function — SIRT3 is the primary mitochondrial quality control deacetylase
• Circadian Clock Mechanisms — SIRT1 deacetylates BMAL1 and PER2, tuning circadian oscillations